| Characteristic . | Arm A, 2 Doses IPV (n = 125) . | Arm B, 2 Doses fIPV (n = 125) . | P Value . | Arm C, 2 Doses IPV (n = 125) . | Arm D, 1 × IPV 1 × fIPV (n = 125) . | P Value . |
|---|---|---|---|---|---|---|
| Sex male, n/N (%) | 56/125 (45) | 76/125 (61) | .011 | 60/125 (48) | 74/125 (59) | .076 |
| Age at enrollment, wk, median (IQR) | 15.7 (14.6–16.9) | 15.1 (14.4–16.4) | .110 | 40 (39.4–41.6) | 40 (39.6–41.7) | .310 |
| Chronic malnutrition moderate and severe, n/N (%) | 30/109 (28) | 30/107 (28) | .930 | 34/92 (37) | 31/90 (34.4) | .720 |
| Monthly income >PKR 10 000, n/N (%)a | 81/125 (65) | 72/125 (58) | .370 | 86/125 (69) | 79/125 (63) | .380 |
| No. of persons sharing household, mean ± SD | 8.9 ± 4.7 | 8.4 ± 3.9 | .370 | 8.6 ± 4.4 | 8.9 ± 4.6 | .590 |
| Ever breastfeed, n/N (%) | 110/114 (97) | 117/119 (98) | .380 | 118/122 (97) | 112/118 (95) | .480 |
| Characteristic . | Arm A, 2 Doses IPV (n = 125) . | Arm B, 2 Doses fIPV (n = 125) . | P Value . | Arm C, 2 Doses IPV (n = 125) . | Arm D, 1 × IPV 1 × fIPV (n = 125) . | P Value . |
|---|---|---|---|---|---|---|
| Sex male, n/N (%) | 56/125 (45) | 76/125 (61) | .011 | 60/125 (48) | 74/125 (59) | .076 |
| Age at enrollment, wk, median (IQR) | 15.7 (14.6–16.9) | 15.1 (14.4–16.4) | .110 | 40 (39.4–41.6) | 40 (39.6–41.7) | .310 |
| Chronic malnutrition moderate and severe, n/N (%) | 30/109 (28) | 30/107 (28) | .930 | 34/92 (37) | 31/90 (34.4) | .720 |
| Monthly income >PKR 10 000, n/N (%)a | 81/125 (65) | 72/125 (58) | .370 | 86/125 (69) | 79/125 (63) | .380 |
| No. of persons sharing household, mean ± SD | 8.9 ± 4.7 | 8.4 ± 3.9 | .370 | 8.6 ± 4.4 | 8.9 ± 4.6 | .590 |
| Ever breastfeed, n/N (%) | 110/114 (97) | 117/119 (98) | .380 | 118/122 (97) | 112/118 (95) | .480 |
Abbreviation: fIPV, fractional inactivated poliovirus vaccine.
aUS$ 1 = PKR 150.
| Characteristic . | Arm A, 2 Doses IPV (n = 125) . | Arm B, 2 Doses fIPV (n = 125) . | P Value . | Arm C, 2 Doses IPV (n = 125) . | Arm D, 1 × IPV 1 × fIPV (n = 125) . | P Value . |
|---|---|---|---|---|---|---|
| Sex male, n/N (%) | 56/125 (45) | 76/125 (61) | .011 | 60/125 (48) | 74/125 (59) | .076 |
| Age at enrollment, wk, median (IQR) | 15.7 (14.6–16.9) | 15.1 (14.4–16.4) | .110 | 40 (39.4–41.6) | 40 (39.6–41.7) | .310 |
| Chronic malnutrition moderate and severe, n/N (%) | 30/109 (28) | 30/107 (28) | .930 | 34/92 (37) | 31/90 (34.4) | .720 |
| Monthly income >PKR 10 000, n/N (%)a | 81/125 (65) | 72/125 (58) | .370 | 86/125 (69) | 79/125 (63) | .380 |
| No. of persons sharing household, mean ± SD | 8.9 ± 4.7 | 8.4 ± 3.9 | .370 | 8.6 ± 4.4 | 8.9 ± 4.6 | .590 |
| Ever breastfeed, n/N (%) | 110/114 (97) | 117/119 (98) | .380 | 118/122 (97) | 112/118 (95) | .480 |
| Characteristic . | Arm A, 2 Doses IPV (n = 125) . | Arm B, 2 Doses fIPV (n = 125) . | P Value . | Arm C, 2 Doses IPV (n = 125) . | Arm D, 1 × IPV 1 × fIPV (n = 125) . | P Value . |
|---|---|---|---|---|---|---|
| Sex male, n/N (%) | 56/125 (45) | 76/125 (61) | .011 | 60/125 (48) | 74/125 (59) | .076 |
| Age at enrollment, wk, median (IQR) | 15.7 (14.6–16.9) | 15.1 (14.4–16.4) | .110 | 40 (39.4–41.6) | 40 (39.6–41.7) | .310 |
| Chronic malnutrition moderate and severe, n/N (%) | 30/109 (28) | 30/107 (28) | .930 | 34/92 (37) | 31/90 (34.4) | .720 |
| Monthly income >PKR 10 000, n/N (%)a | 81/125 (65) | 72/125 (58) | .370 | 86/125 (69) | 79/125 (63) | .380 |
| No. of persons sharing household, mean ± SD | 8.9 ± 4.7 | 8.4 ± 3.9 | .370 | 8.6 ± 4.4 | 8.9 ± 4.6 | .590 |
| Ever breastfeed, n/N (%) | 110/114 (97) | 117/119 (98) | .380 | 118/122 (97) | 112/118 (95) | .480 |
Abbreviation: fIPV, fractional inactivated poliovirus vaccine.
aUS$ 1 = PKR 150.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
